Clinical Trial Update: Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome [NA]

View source ↗

Summary

The study evaluating autologous adipose-derived stem cells for frailty syndrome has been withdrawn; no results or data were reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frailty Syndrome

Drugs mentioned

• Autologous adipose-derived stem cells (adipose-derived stem cells)

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Frailty Syndrome | NA | Status: WITHDRAWN